Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Acta Paediatrica, 2023
Understanding the immune profile of sudden infant death syndrome – proteomic perspectives

Ferrante L., Opdal S., Byard R.

Olink Target 96Other Diseases & SyndromesPathophysiologyCSF

Cancer Epidemiology, Biomarkers & Prevention, 2023
Genome-Wide Association and Two-Sample Mendelian Randomization Analyses of Plasma Ghrelin and Gastrointestinal Cancer Risk

Larsson S., Höijer J., Sun J. et al.

Olink Target 96OncologyPathophysiologyPlasma

Scientific Reports, 2023
Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB

Petrova R., Patil A., Trinh V. et al.

Olink Target 96 MouseOther Diseases & SyndromesPathophysiologySerumCSFMouse Tissue Lysate

Nature, 2023
Rare variant associations with plasma protein levels in the UK Biobank

Dhindsa R., Burren O., Sun B. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

Nature, 2023
Plasma proteomic associations with genetics and health in the UK Biobank

Sun B., Chiou J., Traylor M. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

Journal of Neuroinflammation, 2023
Proteomic profiling identifies novel inflammation-related plasma proteins associated with ischemic stroke outcome

Angerfors A., Brännmark C., Lagging C. et al.

Olink Target 96CVDNeurovascular DiseasesPatient StratificationPlasma

Annals of the American Thoracic Society, 2023
Sleep Apnea Indices Associated with Markers of Inflammation and Cardiovascular Disease: A Proteomic Study in the MUSTACHE Cohort

Ljunggren M., Zhou X., Theorell-Haglöw J. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

Redox Biology, 2023
Age-related influence on DNA damage, proteomic inflammatory markers and oxidative stress in hospitalized COVID-19 patients compared to healthy controls

Draxler A., Blaschke A., Binar J. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Nature Medicine, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Galsky M., Daneshmand S., Izadmehr S. et al.

Olink Target 96OncologyPathophysiologyPlasmaUrine

Cell, 2023
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth

Wimmers F., Burrell A., Feng Y. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasmaNasal Mucus Swabs

ESC Heart Failure, 2023
Plasma tumour necrosis factor‐alpha‐related proteins in prognosis of heart failure with pulmonary hypertension

Engel Sällberg A., Helleberg S., Ahmed S. et al.

Olink Target 96CVDPatient StratificationPlasma

Molecular Metabolism, 2023
Genome-wide meta-analysis of 92 cardiometabolic protein serum levels

Gilly A., Park Y., Tsafantakis E. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologySerum

Clinica Chimica Acta, 2023
Clinical value of droplet digital PCR in the diagnosis and dynamic monitoring of suspected bacterial bloodstream infections

Li M., Zhao L., Zhu Y. et al.

Olink Target 96Infectious DiseasesTechnical EvaluationPlasma

Journal of Allergy and Clinical Immunology, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo

Guttman-Yassky E., Del Duca E., Da Rosa J. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Allergy, 2023
Household laundry detergents disrupt barrier integrity and induce inflammation in mouse and human skin

Rinaldi A., Li M., Barletta E. et al.

Olink Target 96 MouseImmunological & Inflammatory DiseasesEnvironmental Health & ToxicologyPathophysiologyTissue Lysate

Kidney International, 2023
A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation

Lanktree M., Perrot N., Smyth A. et al.

Olink Target 96NephrologyPathophysiologyPlasma

Circulation: Genomic and Precision Medicine, 2023
Combining Polygenic and Proteomic Risk Scores With Clinical Risk Factors to Improve Performance for Diagnosing Absence of Coronary Artery Disease in Patients With de novo Chest Pain

Møller P., Rohde P., Dahl J. et al.

Olink Target 96CVDPatient Stratification

Circulation: Heart Failure, 2023
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study

Buckley L., Agha A., Dorbala P. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Functional Foods, 2023
High-parameter immune profiling and subjective health assessment of the immunomodulatory effects of paramylon-rich Euglena gracilis EOD-1: A randomized, double-blind, placebo-controlled, parallel-group study

Kawano T., Miura A., Naito J. et al.

Olink Target 48Nutritional SciencePathophysiologySerum

Science Advances, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

Rejeski K., Perez A., Iacoboni G. et al.

Olink Target 96OncologyPathophysiologySerum

3144 publications